首页> 美国卫生研究院文献>Turkish Journal of Hematology >Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis
【2h】

Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis

机译:在因侵袭性肺曲霉病引起的大规模咯血的青少年中成功使用重组因子VIIa和卷材栓塞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Invasive fungal infections have turned out to be a significant cause of morbidity and mortality in pediatric patients with malignant disorders. Massive hemoptysis, a rare complication of invasive pulmonary aspergillosis, may threaten the lives of patients, usually during the resolution of neutropenia. In this report, we describe a patient with massive hemoptysis due to invasive pulmonary aspergillosis whose bleeding was controlled successfully with off-label use of recombinant factor VIIa and subsequent coil embolization of the right pulmonary artery.
机译:在患有恶性疾病的小儿患者中,侵入性真菌感染已被证明是发病率和死亡率的重要原因。大规模咯血是侵袭性肺曲霉病的罕见并发症,通常在中性粒细胞减少症发作期间可能威胁患者的生命。在本报告中,我们描述了由于侵袭性肺曲霉病而导致大量咯血的患者,其出血已成功通过标记外使用重组因子VIIa和随后的右肺动脉线圈栓塞得以成功控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号